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Summary  Mononucleosis  and  mononucleosis-like  illnesses  comprise  a  signiﬁcant
proportion  of  pediatric  and  adolescent  infectious  illnesses.  By  far,  the  most  com-
mon  cause  of  these  illnesses  is  Epstein—Barr  virus,  which  causes  mononucleosis,
and  a  distant  second  is  cytomegalovirus,  which  is  the  most  common  cause  of
mononucleosis-like  illnesses.  This  case  provides  an  interesting  juxtaposition  of  lab-
oratory  ﬁndings  of  an  adolescent  who  was  heterophile  antibody  positive  but  acute
Epstein—Barr  virus  antigen—antibody  negative.  A  subsequent  immunologic  assay
resulted  in  a  ﬁnal  diagnosis  of  an  acute  cytomegaloviral  infection.  This  is,  to  ourLeukopenia  of
unknown  etiology;
Atypical  viral  infection
in an
immunocompetent
knowledge,  the  ﬁrst  such  report  in  the  literature.
©  2014  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.
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ytomegalovirus  (CMV)  and  Epstein—Barr  virus
EBV) are  fairly  common  infectious  agents  as
llustrated  by  the  high  seropositivity  of  immuno-
ompetent adults  against  both  viruses  [1,2]. The
ransmission  of  both  viruses  is  usually  through  an
xchange  of  oral  or  other  bodily  ﬂuids,  either  by
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876-0341/© 2014 King Saud Bin Abdulaziz University for Health Scieirect  contact  or  through  a fomite  [1,2]. For  most
ndividuals,  a sub-clinical  acute  course  is  expected;
owever,  there  is  a  signiﬁcant  proportion  of  individ-
als who  suffer  from  more  clinically  apparent  acute
iral infections.  Both  infections,  if  symptomatic,
ay present  similarly  [1,3,4].
In  general  greater  than  90%  of  patients  sus-
ected of  having  infectious  mononucleosis  (IM)  or
ononucleosis-like  illness  (MLI)  have  an  acute  EBV
nfection [3]. Most  of  these  cases  are  supported  by
nces. Published by Elsevier Ltd. All rights reserved.
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conﬁrmatory  serology,  and  CMV  is  only  suspected  in
the setting  of  a  negative  heterophile  antibody  test
[3,4].
The case  presented  here  is unusual  with  regard
to the  demographics  of  the  patient,  the  relative
absence of  the  most  common  symptoms  of  CMV  MLI,
and the  conﬂicting  laboratory  results.  To  our  knowl-
edge, this  is  the  ﬁrst  report  of  an  Epstein—Barr
virus naïve,  heterophile  antibody  positive,  acute
cytomegaloviral  infection.
A 12-year-old  Hispanic-American  male  was
brought by  his  father  to  his  pediatrician’s  ofﬁce
with complaints  of  fatigue,  night  sweats,  fever,  and
headache.  The  patient’s  symptoms  began  approx-
imately  four  days  previously  and  were  worse  at
night. The  fever  was  quantiﬁed  at  home  with  a
Tmax of  38.6 ◦C,  and  the  patients  were  treated
with ibuprofen.  The  patient  denied  any  changes  in
appetite,  weight  loss,  coughing,  nausea,  vomiting,
shortness  of  breath,  or  abdominal  pain.  No  signif-
icant  past  medical  history  was  noted.  Aside  from
ibuprofen,  no  current  medication  use  was  noted.
The patient  had  not  traveled  in  the  past  six  months.
The patient’s  vital  signs  were  within  normal
limits, and  on  physical  exam,  no  abnormalities
were noted.  The  physical  exam  included  a visual
inspection of  the  oropharynx,  a  fundoscopic  exami-
nation  to  exclude  increased  intracranial  pressure,
tactile  examination  for  lymphadenopathy,  car-
diopulmonary  auscultation,  abdominal  palpation,
and  inspection  for  rashes.
A rapid  Inﬂuenza  A  and  B  and  a  puriﬁed
protein  derivative  test  were  ordered  and  per-
formed in  the  clinic  and  found  to  be  negative
after 30  min  and  72  h,  respectively.  In  addition,
a chest  X-ray  was  performed  that  did  not  illus-
trate any  acute  cardiopulmonary  abnormalities,
opaciﬁcations,  or  granulomatous  foci.  Laboratory
investigations (Quest  Diagnostics,  Miramar,  FL)
included a  complete  blood  count,  a  comprehen-
sive metabolic  panel,  a  lipid  proﬁle  panel,  and  a
urinalysis.  Signiﬁcant  abnormalities  noted  included
a low  white  blood  cell  count  of  2.9  × 103 L  with
neutropenia (absolute  neutrophil  count  of  777),
relative  lymphocytosis  suggested  by  a differen-
tial of  51.5%  lymphocytes  and  26.8%  neutrophils,
and mild  transaminitis  with  an  alanine  aminotrans-
ferase of  43  U/L  and  an  aspartate  aminotransferase
of 43  U/L.
At  this  stage,  our  clinical  experience  with
children with  constitutional  symptoms,  leukope-
nia, relative  lymphocytosis,  and  mild  transaminitis
led us  to  suspect  the  patient  was  infected  with
mononucleosis.  Consequently,  a  heterophile  anti-
body test  and  a  conﬁrmatory  EBV  antibodies  test
were ordered  (Quest  Diagnostics,  Miramar,  FL).
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he  monospot  test  was  found  to  be  positive  after
epeat analysis;  however,  the  EBV  viral  capsid  anti-
en (VCA)  Immunoglobulin  M  and  Immunoglobulin  G
IgG) as  well  as  the  EBNA  IgG  tests  were  all  nega-
ive. This  indicated  either  a  false  positive  monospot
r a  false  negative  EBV  antibodies  test,  which  are
oth highly  unusual.
Given  the  high  speciﬁcity  of  the  EBV  antibodies
est and  the  pursuant  higher  negative  predictive
alue of  the  VCA  and  EBNA  tests  compared  with
he lower  positive  predictive  value  of  the  monospot
est for  the  prediction  of  acute  EBV,  we  chose  to
nvestigate  the  possibility  that  a virus  had  cross-
eacted  causing  a false  positive  monospot  in  the
etting  of  an  MLI.  Consequently,  as  the  most  com-
on etiology  of  MLI  is  CMV,  we  performed  anti-CMV
erology testing.  The  IgG  level  of  CMV  was  unde-
ectable; however,  the  anti-CMV  IgM  was  found
o be  2.5  times  the  upper  limit  of  normal  at
.7 U.
At  this  stage,  the  patient’s  parents  were
ontacted and  counseled  regarding  the  ﬁnd-
ng of  an  acute  CMV  infection  causing  a  MLI.
hey were  informed  of  the  necessity  of  ade-
uate hydration,  administering  non-steroidal  anti-
nﬂammatory  medications  for  fever  and  body  aches,
nd avoiding  strenuous  activities.  They  were  also
nformed  of  the  possible,  but  rare,  complications
f MLI.  The  patient  subsequently  improved  and  his
ymptoms  resolved  without  further  intervention.
iscussion
nfectious  mononucleosis  is  a common  viral  syn-
rome that  results  from  an  acute  EBV  infection.  In
ontrast,  mononucleosis-like  illnesses  have  etiolo-
ies ranging  from  viral,  which  is  the  most  common,
o bacterial  and  parasitic  [3]. The  classic  presenta-
ion of  patients  with  IM  is  malaise,  headache,  fever,
on-purulent  pharyngitis,  and  tonsillitis  (though
hick  white  exudate  may  be  present)  accompanied
y cervical  lymphadenopathy,  most  typically  in  the
osterior chain.  More  rarely,  other  signs  may  also
e noted,  including  rash,  splenomegaly,  and  hepa-
omegaly  [1,3,4]. Patients  with  MLI  will  typically
ave similar  but  milder  symptomatology  [1,3].
When IM  or  MLI  is  suspected,  additional  inves-
igations include  a  CBC,  which  frequently  shows
ymphocytosis and/or  atypical  lymphocytes,  liver
unction tests  to  diagnosis  transaminitis,  and  the
eterophile  antibody  (or  monospot)  test  [1,3,4].
he monospot  test  is  predicated  on  the  fact
hat IgM  antibodies  in  the  serum  are  generated
gainst glycoproteins  on  EBV  infected  cells  (i.e.,
he Paul—Bunnell  antigen)  as  well  as (rarely)  CMV
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nfected  cells  and  can  cross-react  with  animal
rythrocytes to  cause  agglutination  [3,5]. The
onospot  test  is 87%  sensitive  with  a  conﬁdence
nterval (CI)  of  79—95%  and  is  91%  speciﬁc  (CI
2—99%) for  IM  [4].
Conﬁrmation  of  an  EBV  infection  is generally
btained by  the  detection  of  antibodies  to  the  VCA
f EBV  and  by  a  positive  EBV  nuclear  antigen  (EBNA)
est. These  assays  are  even  more  sensitive  (97%,
I 95—99%)  and  speciﬁc  (94%,  CI  89—99%)  for  IM
han the  monospot  test  [3,4]. During  the  course  of
M, VCA  IgM  and  IgG  are  produced  before  the  het-
rophile antibody,  which  reaches  its  peak  level  two
o ﬁve  weeks  after  the  initial  infection.  Thus,  tests
or the  heterophile  antibody  are  falsely  negative  in
ne-fourth  of  IM  patients  in  the  ﬁrst  week,  mak-
ng tests  for  VCA  and  EBNA  more  deﬁnitive  for  the
iagnosis  of  acute  EBV  infection  [3].
MLI is  frequently  considered  when  a  clinical
resentation  is  similar  to  IM  with  a  negative
eterophile antibody  (or  monospot)  test  and/or
egative anti-EBV  serology  [4].  Moreover,  92%  of
LI cases  (versus  just  over  50%  of  acute  EBV  cases)
re found  to  have  transaminitis  [1,3]. The  demo-
raphic that  most  commonly  presents  with  CMV  MLI
s women  in  their  twenties  [2].
In the  setting  of  a  CMV  infection,  it  is  possible
o note  anemia  and  thrombocytopenia  on  a  CBC  as
ell as  cold  agglutinins  [1]. Anti-CMV  serology,  spin
mpliﬁed  urine  culture  for  pp65  antigen  detection,
nd/or CMV  polymerase  chain  reaction  (PCR)  can
e used  to  deﬁnitively  detect  the  presence  of  an
cute CMV  infection  [1,3,4].
In our  case,  a  strongly  positive  anti-CMV  IgMest result  following  a  negative  EBNA  and  VCA  test
esult,  even  in  the  setting  of  a  positive  monospot
est, was  adequate  to  conﬁrm  our  diagnosis  of
cute MLI  and  its  CMV  etiology.  The  negative  EBNA
[
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nd  VCA  results  following  a positive  monospot  test
eﬁnitively  excluded  EBV  as  the  etiological  cause  of
he illness  given  EBNA  and  VCA  would  rise  before  a
rue positive  monospot.  This  precluded  the  idea  of
gM false  positivity  for  CMV.  However,  this  new  sero-
ogical proﬁle  raises  questions  for  future  research
egarding  possible  cross-reactivity  of  anti-CMV  IgM
ith the  Paul—Bunnell  antigenic  glycoproteins.
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